Dr. Reddys Laboratories Ltd.
BSE: 500124 | NSE: DRREDDY
Mid Cap | Pharmaceuticals & Drugs
1234.60
-10.90 (-0.88%) Dr Reddys Laboratories informs about press release
Date: 17-02-2021Dr. Reddys Laboratories has informed that it has enclosed a Press Release on 17th February 2021 titled ‘Dr. Reddy's Laboratories announces the launch of Capecitabine Tablets, USP in the U.S. Market’.
The above information is a part of company’s filings submitted to BSE.